Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Neuroreport
|
August 20, 2014
Sex differences in the modulation of emotional processing by expectation
Huiyan Lin, Jiafeng Liang, Weiyun Xie, et al.
Discover Oncology
|
July 30, 2024
Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity
Kaicheng Pan, Bing Wang, Xiao Xu, et al.
Discover Oncology
|
September 30, 2024
Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation
Jiafeng Liang, Lucheng Zhu, Jiawei Li, et al.
Optics Express
|
November 25, 2018
Generalized inverse matrix-exterior penalty function (GIM-EPF) algorithm for data processing of multi-wavelength pyrometer (MWP)
Jiafeng Liang, Li Dai, Sheng Chen, et al.
Discover Oncology
|
April 8, 2025
Efficacy analysis of brain radiotherapy in EGFR mutation non-small cell lung cancer with brain metastasis: a retrospective study
Kaicheng Pan, Bing Wang, Xiao Xu, et al.
Molecular Immunology
|
December 10, 2022
The second-generation tyrosine kinase inhibitor afatinib inhibits IL-1β secretion via blocking assembly of NLRP3 inflammasome independent of epidermal growth factor receptor signaling in macrophage
Shujun Xie, Jiafeng Liang, Yanyan Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 24, 2025
Combination of anlotinib and irinotecan as second-line therapy in extensive-stage small-cell lung cancer relapsed within six months: a single-arm phase Ⅱ study
Minna Zhang, Yi Tang, Jiafeng Liang, et al.
Discover Oncology
|
June 24, 2026
Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer
Jiafeng Liang, Lucheng Zhu, Kan Wu, et al.
BMC Cancer
|
May 8, 2021
Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study
Lucheng Zhu, Changlin Zou, Zhanchun Zhang, et al.
Journal of Thoracic Disease
|
January 12, 2026
Development of a machine learning-based model to predict prognosis of resected invasive pulmonary adenocarcinoma
Jie Huang, Jiannan Qian, Yunshan Zhong, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Neuroreport
|
August 20, 2014
Sex differences in the modulation of emotional processing by expectation
Huiyan Lin, Jiafeng Liang, Weiyun Xie, et al.
Discover Oncology
|
July 30, 2024
Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity
Kaicheng Pan, Bing Wang, Xiao Xu, et al.
Discover Oncology
|
September 30, 2024
Comprehensive analysis to identify IL7R as a immunotherapy biomarker from pan-cancer analysis to in vitro validation
Jiafeng Liang, Lucheng Zhu, Jiawei Li, et al.
Optics Express
|
November 25, 2018
Generalized inverse matrix-exterior penalty function (GIM-EPF) algorithm for data processing of multi-wavelength pyrometer (MWP)
Jiafeng Liang, Li Dai, Sheng Chen, et al.
Discover Oncology
|
April 8, 2025
Efficacy analysis of brain radiotherapy in EGFR mutation non-small cell lung cancer with brain metastasis: a retrospective study
Kaicheng Pan, Bing Wang, Xiao Xu, et al.
Molecular Immunology
|
December 10, 2022
The second-generation tyrosine kinase inhibitor afatinib inhibits IL-1β secretion via blocking assembly of NLRP3 inflammasome independent of epidermal growth factor receptor signaling in macrophage
Shujun Xie, Jiafeng Liang, Yanyan Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 24, 2025
Combination of anlotinib and irinotecan as second-line therapy in extensive-stage small-cell lung cancer relapsed within six months: a single-arm phase Ⅱ study
Minna Zhang, Yi Tang, Jiafeng Liang, et al.
Discover Oncology
|
June 24, 2026
Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer
Jiafeng Liang, Lucheng Zhu, Kan Wu, et al.
BMC Cancer
|
May 8, 2021
Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study
Lucheng Zhu, Changlin Zou, Zhanchun Zhang, et al.
Journal of Thoracic Disease
|
January 12, 2026
Development of a machine learning-based model to predict prognosis of resected invasive pulmonary adenocarcinoma
Jie Huang, Jiannan Qian, Yunshan Zhong, et al.
Page
of 5